Published in Immunol Today on October 01, 1996
Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol (1997) 2.47
Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease. Gut (2001) 1.88
Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. J Virol (1998) 1.71
A primer on cytokines: sources, receptors, effects, and inducers. Clin Microbiol Rev (1997) 1.57
HIV envelope gp120 activates human arterial smooth muscle cells. Proc Natl Acad Sci U S A (2001) 1.33
Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. Proc Natl Acad Sci U S A (1997) 1.19
Evolutionary divergence and functions of the human interleukin (IL) gene family. Hum Genomics (2010) 1.15
Insights into the role of fibroblasts in human autoimmune diseases. Clin Exp Immunol (2005) 1.10
Production of IL-16 correlates with CD4+ Th1 inflammation and phosphorylation of axonal cytoskeleton in multiple sclerosis lesions. J Neuroinflammation (2006) 1.10
Gene expression profiling of human macrophages at late time of infection with Mycobacterium tuberculosis. Immunology (2006) 1.02
GA-binding protein factors, in concert with the coactivator CREB binding protein/p300, control the induction of the interleukin 16 promoter in T lymphocytes. Proc Natl Acad Sci U S A (1999) 1.00
Recombinant interleukin-16 selectively modulates surface receptor expression and cytokine release in macrophages and dendritic cells. Immunology (1999) 0.99
Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells. J Virol (1999) 0.89
Recombinant human IL-16 inhibits HIV-1 replication and protects against activation-induced cell death (AICD). Clin Exp Immunol (1998) 0.88
Human B-cell lines constitutively express and secrete interleukin-16. Immunology (2000) 0.86
Impaired survival of T helper cells in the absence of CD4. Proc Natl Acad Sci U S A (2001) 0.85
Inhibitory effect of interleukin-16 on interleukin-2 production by CD4+ T cells. Immunology (1999) 0.84
HIV-1 envelope gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes. J Clin Invest (1998) 0.83
Chemotactic factors in cerebrospinal fluid during bacterial meningitis. Infect Immun (2006) 0.81
Kinetics of lymphokine production in HIV+ patients treated with highly active antiretroviral therapy and interleukin 2. J Clin Immunol (1999) 0.80
Heightened ability of monocytes from sarcoidosis patients to form multi-nucleated giant cells in vitro by supernatants of concanavalin A-stimulated mononuclear cells. Clin Exp Immunol (2001) 0.80
Interleukin-16 polymorphism is associated with an increased risk of ischemic stroke. Mediators Inflamm (2013) 0.79
A Study on Genetic Association of Interleukin-16 Single Nucleotide Polymorphism (rs1131445) With Chronic Hepatitis B Virus Infection in Iranian Patients. Jundishapur J Microbiol (2015) 0.79
Immune abnormalities induced by human endogenous retroviral peptides: with reference to the pathogenesis of systemic lupus erythematosus. J Clin Immunol (2003) 0.79
Cells and molecules involved in the development of sarcoid granuloma. J Clin Immunol (1998) 0.79
The leech nervous system: a valuable model to study the microglia involvement in regenerative processes. Clin Dev Immunol (2013) 0.78
The role of interleukin-16 in murine contact hypersensitivity. Clin Exp Immunol (2005) 0.78
Genetic polymorphisms of interleukin-16 and risk of knee osteoarthritis. PLoS One (2015) 0.78
Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms. World J Gastroenterol (2016) 0.75
Structure of a Potential Therapeutic Antibody Bound to Interleukin-16 (IL-16): MECHANISTIC INSIGHTS AND NEW THERAPEUTIC OPPORTUNITIES. J Biol Chem (2016) 0.75
Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J Immunol (2000) 3.19
Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun (1997) 2.85
T-lymphocyte subpopulations in homosexual men. N Engl J Med (1982) 2.72
Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses. Nature (1987) 2.61
Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J Immunol (1998) 2.55
Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect Immun (1997) 2.16
Lymphocyte activation by HIV-1 envelope glycoprotein. Nature (1988) 2.15
Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquir Immune Defic Syndr (1992) 1.95
A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. Proc Natl Acad Sci U S A (1997) 1.67
Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc Natl Acad Sci U S A (1994) 1.65
Interleukin-16. J Leukoc Biol (2000) 1.59
CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J Exp Med (1991) 1.58
Lymphokine activation of T4+ T lymphocytes and monocytes. J Immunol (1987) 1.58
Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect Immun (1994) 1.57
Macrophage apoptosis in mycobacterial infections. J Leukoc Biol (1999) 1.51
Vbeta8+ T lymphocytes are essential in the regulation of airway hyperresponsiveness and bronchoalveolar eosinophilia but not in allergen-specific IgE in a murine model of allergic asthma. Clin Exp Allergy (1998) 1.43
Regulation of endothelial cell glyceraldehyde-3-phosphate dehydrogenase expression by hypoxia. J Biol Chem (1994) 1.38
Lymphocyte recruitment to the lung. Am Rev Respir Dis (1990) 1.37
Induction of human T lymphocyte motility by interleukin 2. J Immunol (1985) 1.35
Processing and activation of pro-interleukin-16 by caspase-3. J Biol Chem (1998) 1.34
TNF-dependent BALB/c murine macrophage apoptosis following Mycobacterium tuberculosis infection inhibits bacillary growth in an IFN-gamma independent manner. Tuberculosis (Edinb) (2002) 1.33
Expansion of a CD8+CD28- cell population in the blood and lung of HIV-positive patients. J Acquir Immune Defic Syndr (1993) 1.30
Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro. J Immunol (1992) 1.28
Human eosinophils express functional interleukin 2 receptors. J Clin Invest (1991) 1.26
Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES. J Immunol (1996) 1.20
Histamine-induced secretion of lymphocyte chemoattractant factor from CD8+ T cells is independent of transcription and translation. Evidence for constitutive protein synthesis and storage. J Immunol (1995) 1.18
Increased expression of interleukin-16 in bronchial mucosa of subjects with atopic asthma. Am J Respir Cell Mol Biol (1997) 1.16
Evolution of a simian immunodeficiency virus pathogen. J Virol (1998) 1.15
Induction of human monocyte motility by lysyl oxidase. Matrix Biol (1995) 1.12
Cultured human fibroblasts express constitutive IL-16 mRNA: cytokine induction of active IL-16 protein synthesis through a caspase-3-dependent mechanism. J Immunol (2000) 1.09
Synergistic activation of CD4+ T cells by IL-16 and IL-2. J Immunol (1998) 1.09
CD4 ligand IL-16 inhibits the mixed lymphocyte reaction. J Immunol (1996) 1.08
B lymphocyte-derived IL-16 attracts dendritic cells and Th cells. J Immunol (2000) 1.07
Cross-reactivity to human T-lymphotropic virus type III/lymphadenopathy-associated virus and molecular cloning of simian T-cell lymphotropic virus type III from African green monkeys. Proc Natl Acad Sci U S A (1986) 1.06
Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset. Cell Immunol (1985) 1.06
Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J Immunol (1997) 1.05
Lymphocyte motility and lymphocyte chemoattractant factors. Immunol Invest (1989) 1.04
A role for IL-16 in the cross-talk between dendritic cells and T cells. J Immunol (1999) 1.04
Chemokine and matrix metalloproteinase secretion by myelin proteolipid protein-specific CD8+ T cells: potential roles in inflammation. J Immunol (1997) 1.02
Pulmonary presentation of Kaposi's sarcoma in a homosexual patient. Am Rev Respir Dis (1983) 1.01
Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis. J Immunol (1999) 1.00
Tissue and T cell distribution of precursor and mature IL-16. J Immunol (1998) 0.99
Involvement of IL-16 in the induction of airway hyper-responsiveness and up-regulation of IgE in a murine model of allergic asthma. J Immunol (1998) 0.99
The CD4-associated tyrosine kinase p56lck is required for lymphocyte chemoattractant factor-induced T lymphocyte migration. J Biol Chem (1995) 0.97
Processing and release of IL-16 from CD4+ but not CD8+ T cells is activation dependent. J Immunol (1999) 0.97
Interleukin 16: implications for CD4 functions and HIV-1 progression. Immunol Today (2000) 0.97
Enhanced in vivo human immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia. Am J Respir Crit Care Med (1999) 0.97
IL-16 represses HIV-1 promoter activity. J Immunol (1997) 0.97
Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1 alpha (MIP1 alpha) in bronchoalveolar lavage fluid of antigen-challenged asthmatics. Am J Respir Cell Mol Biol (1995) 0.95
Airway epithelial Fas ligand expression: potential role in modulating bronchial inflammation. Am J Physiol (1998) 0.94
Macrophage stimulation with Murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signal-regulated kinases 1 and 2, C/EBPbeta and STAT1: role of CD14 and Toll-like receptors 2 and 4. Eur J Immunol (2001) 0.93
Signaling and functional properties of interleukin-16. Int Rev Immunol (1998) 0.93
CD8+ myelin peptide-specific T cells can chemoattract CD4+ myelin peptide-specific T cells: importance of IFN-inducible protein 10. J Immunol (1998) 0.93
Nuclear weapons and civil defense. The influence of the medical profession in 1955 and 1983. West J Med (1983) 0.92
The lymphocyte chemoattractant factor. J Lab Clin Med (1995) 0.92
Secretion of IL-16 (lymphocyte chemoattractant factor) from serotonin-stimulated CD8+ T cells in vitro. J Immunol (1996) 0.92
HIV-1 envelope protein (gp120) inhibits the activity of human bronchoalveolar macrophages against Cryptococcus neoformans. Am Rev Respir Dis (1992) 0.91
Phagocytosis and growth inhibition of Cryptococcus neoformans by human alveolar macrophages: effects of HIV-1 infection. AIDS (1996) 0.90
Decreased renal ischemia-reperfusion injury by IL-16 inactivation. Kidney Int (2007) 0.90
Conservation of structure and function between human and murine IL-16. J Immunol (1998) 0.89
Modulation of airway hyperresponsiveness and eosinophilia by selective histamine and 5-HT receptor antagonists in a mouse model of allergic asthma. Br J Pharmacol (1998) 0.89
Chemotactic activity of mycobacterial lipoarabinomannans for human blood T lymphocytes in vitro. J Immunol (1996) 0.88
IL-16- and other CD4 ligand-induced migration is dependent upon protein kinase C. Cell Immunol (1996) 0.88
Interferon-gamma reduces the capacity of human alveolar macrophages to inhibit growth of Cryptococcus neoformans in vitro. Am J Respir Cell Mol Biol (1996) 0.88
Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand. J Immunol (1983) 0.87
Nuclear translocation of the N-terminal prodomain of interleukin-16. J Biol Chem (2001) 0.87
Variables affecting production of monocyte chemotactic factor 1 from human leukocytes stimulated with Cryptococcus neoformans. Infect Immun (1997) 0.87
The effect of infection with human immunodeficiency virus on the anticryptococcal activity of lymphocytes and monocytes. J Infect Dis (1995) 0.86
Transforming growth factor beta1 and laminin-111 cooperate in the induction of interleukin-16 expression in synovial fibroblasts from patients with rheumatoid arthritis. Ann Rheum Dis (2010) 0.86
Longitudinal relationship of early life immunomodulatory T cell phenotype and function to development of allergic sensitization in an urban cohort. Clin Exp Allergy (2011) 0.86
Role of B7-CD28/CTLA-4 costimulation and NF-kappa B in allergen-induced T cell chemotaxis by IL-16 and RANTES. J Immunol (2000) 0.85
Desensitization of CXC chemokine receptor 4, mediated by IL-16/CD4, is independent of p56lck enzymatic activity. J Immunol (2000) 0.85
Human immunodeficiency virus type 1 infection of alveolar macrophages impairs their innate fungicidal activity. Am J Respir Crit Care Med (2000) 0.85
Biologic activities of HIV-1 envelope glycoprotein: the effects of crosslinking. Biomed Pharmacother (1990) 0.83
Interleukin-16. Int J Biochem Cell Biol (1997) 0.83
Interleukin 16 and T-cell chemoattractant activity in bronchoalveolar lavage 24 hours after allergen challenge in asthma. Am J Respir Crit Care Med (2000) 0.82
IL-16 inhibits IL-5 production by antigen-stimulated T cells in atopic subjects. J Allergy Clin Immunol (2001) 0.82
Identification of a CD4 domain required for interleukin-16 binding and lymphocyte activation. J Biol Chem (1999) 0.82
Lipopolysaccharide binding protein potentiates airway reactivity in a murine model of allergic asthma. J Immunol (2001) 0.82